Literature DB >> 17016583

Characterization of mitochondria in cisplatin-resistant human ovarian carcinoma cells.

Masanori Hirama1, Seiji Isonishi, Makoto Yasuda, Hiroshi Ishikawa.   

Abstract

One of the mechanisms of cisplatin cell cytotoxicity is the mitochondria-associated induction of apoptosis. The morphological or functional change of mitochondria in cisplatin-resistant cells has already been reported. Herein we present additional data describing the mitochondrial genomic and functional changes in cisplatin- resistant cells. Cisplatin increased the level of apoptotic cells in cisplatin-sensitive human ovarian carcinoma OV 2008 and C13 cells by 3.90+/-1.01 (SD; N=3) (p<0.01)-fold and 2.03+/-0.20 (SD; N=3) (p<0.01)-fold compared to the basal apoptotic level. This indicates a lower level induction of apoptosis by 50% in cisplatin-resistant OV 2008/C13 *5.25 variant (C13) cells. In both cell types, cisplatin cytotoxicity is mostly inhibited by the caspase-9 inhibitor as well as the caspase-3 inhibitor, Ac-DEVD-CHO, suggesting that the mitochondrial downstream event was functioning well in both the C13 cells and in OV 2008 cells. Mitochondrial transmembrane potential (DeltaPsim) determined by flow cytometry using DiOC6-stained cells revealed a significant depolarization of C13 cells as compared to OV 2008 cells. Treatment of these cells with cisplatin or hydrogen peroxide induces complete mitochondrial DNA damage in OV 2008 cells, while only partial DNA-destruction is observed in C13 cells, strongly suggesting that mitochondria are resistant to cisplatin and oxidative stress response. Continuous oxygen consumption of these cells monitored by a multi-channel dissolved oxygen meter is 1.70-fold higher in OV 2008 cells than C13 cells and the oxygen consumption was decreased by 30% in C13 cells, suggesting mitochondrial respiratory malfunction in these cells. The hypothesis generated here is that mitochondrial DNA resistance to cisplatin and oxidative stress response might be one of the main characteristics concerning the lower level of apoptosis induced by cisplatin. However, the mechanism by which the mitochondrial DNA encoded molecule is involved in cisplatin resistance remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016583

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  16 in total

1.  Prognostic significance of the mitochondrial scoring system in ovarian cancer.

Authors:  Ryuma Matsumoto; Seiji Isonishi; Kazuhiko Ochiai; Tomomi Hamada; Takako Kiyokawa; Toshiaki Tachibana; Hiroshi Ishikawa
Journal:  Exp Ther Med       Date:  2010-07-20       Impact factor: 2.447

Review 2.  Cisplatin nephrotoxicity: a review of the literature.

Authors:  Sandhya Manohar; Nelson Leung
Journal:  J Nephrol       Date:  2017-04-05       Impact factor: 3.902

3.  Hyper-phosphorylation of Sequestosome-1 Distinguishes Resistance to Cisplatin in Patient Derived High Grade Serous Ovarian Cancer Cells.

Authors:  Elizabeth V Nguyen; Kaisa Huhtinen; Young Ah Goo; Katja Kaipio; Noora Andersson; Ville Rantanen; Johanna Hynninen; Riitta Lahesmaa; Olli Carpen; David R Goodlett
Journal:  Mol Cell Proteomics       Date:  2017-04-28       Impact factor: 5.911

Review 4.  Mechanism of kidney injury induced by cisplatin.

Authors:  Guochen Huang; Qian Zhang; Chunming Xu; Long Chen; Hongxia Zhang
Journal:  Toxicol Res (Camb)       Date:  2022-05-12       Impact factor: 2.680

5.  Targeting mitochondrial DNA with a platinum-based anticancer agent.

Authors:  Simon P Wisnovsky; Justin J Wilson; Robert J Radford; Mark P Pereira; Maria R Chan; Rebecca R Laposa; Stephen J Lippard; Shana O Kelley
Journal:  Chem Biol       Date:  2013-10-31

Review 6.  Mechanisms of Cisplatin nephrotoxicity.

Authors:  Ronald P Miller; Raghu K Tadagavadi; Ganesan Ramesh; William Brian Reeves
Journal:  Toxins (Basel)       Date:  2010-10-26       Impact factor: 4.546

7.  Effects of Cisplatin in neuroblastoma rat cells: damage to cellular organelles.

Authors:  Giada Santin; Luigi Scietti; Paola Veneroni; Sergio Barni; Graziella Bernocchi; Maria Grazia Bottone
Journal:  Int J Cell Biol       Date:  2012-02-28

8.  Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma.

Authors:  Yu-Chi Su; Goutham Venkata Naga Davuluri; Cheng-Hao Chen; Dong-Che Shiau; Chien-Chin Chen; Chia-Ling Chen; Yee-Shin Lin; Chih-Peng Chang
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

9.  Activation of surrogate death receptor signaling triggers peroxynitrite-dependent execution of cisplatin-resistant cancer cells.

Authors:  S Seah; I C C Low; J L Hirpara; K Sachaphibulkij; G Kroemer; C Brenner; S Pervaiz
Journal:  Cell Death Dis       Date:  2015-10-22       Impact factor: 8.469

10.  Reduction in mitochondrial oxidative stress mediates hypoxia-induced resistance to cisplatin in human transitional cell carcinoma cells.

Authors:  Myung-Chul Kim; Sung-Hyun Hwang; Yeseul Yang; Na-Yon Kim; Yongbaek Kim
Journal:  Neoplasia       Date:  2021-06-13       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.